Skip to content

Lung Injury from Military Deployment

Search Clinical Trials

Trial Objectives


The purpose of this study is to learn more about lung disease found in contractors and U.S. military personnel serving in Iraq and Afghanistan after September 11, 2001. The information collected with be used to learn about respiratory diseases associated with the inhalation of very small particulate matter and other harmful substances during deployment.

Who Can Participate


Patients who have been seen at National Jewish Health for evaluation of respiratory symptoms and have been deployed during Operation Iraqi Freedom, Operation Enduring Freedom, Operation New Dawn or Operation Freedom’s Sentinel.

Age: 18-70 Gender Any

Estimated Time Commitment


1 to 2 visits

Payment & Reimbursement


Payment Provided

Travel Reimbursement Not Available

Trial Contact


For more information, contact:

Kathy Pang
303.398.1418

 

Michelle Kramaric
303.398.1748

Request More Information

Trial Location


National Jewish Main Campus, Denver, CO

Trial Sponsors


Department of Defense

Principal Investigators

Gregory P. Downey

Gregory P. Downey, MD

Co-Investigators

  • Hong Wei Chu

    Hong Wei Chu, MD

  • Brian J. Day

    Brian J. Day, PhD

  • Cecile S. Rose

    Cecile S. Rose, MD, MPH

  • Max Seibold

    Max Seibold, PhD

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health required